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Abstract
Double catalytic enantioselective transformations are powerful synthetic methods that can facilitate
the construction of stereochemically complex molecules in a single operation1,2. In addition to
generating two or more stereocentres in a single reaction, multiple asymmetric reactions also impart
increased enantiomeric excess to the final product in comparison with the analogous single
transformation3-6. Furthermore, multiple asymmetric operations have the potential to independently
construct several stereocentres at remote points within the same molecular scaffold, rather than
relying on pre-existing chiral centres that are proximal to the reactive site1. Despite the inherent
benefits of multiple catalytic enantioselective reactions, their application to natural product total
synthesis remains largely underutilized2. Here we report the use of a double stereoablative7
enantioselective alkylation reaction in a concise synthesis of the marine diterpenoid (–)-cyanthiwigin
F (ref. 8). By employing a technique for independent, selective formation of two stereocentres in a
single stereoconvergent operation, we demonstrate that a complicated mixture of racemic and meso
diastereomers may be smoothly converted to a synthetically useful intermediate with exceptional
enantiomeric excess. The stereochemical information generated by means of this catalytic
transformation facilitates the easy and rapid completion of the total synthesis of this marine natural
product.
Originally isolated from the sea sponge Myrmekioderma styx, cyanthiwigin F (1; see Fig. 1) is
one of 30 known cyanthiwigin natural products, all of which belong to a larger class of bioactive
molecules known as the cyathins8-10. The cyathins display a wide range of biological
properties including antimicrobial activity, antineoplastic action, stimulation of nerve growth
factor synthesis, and κ-opioid receptor agonism9,11. Cyanthiwigin F itself exhibits cytotoxic
activity against human primary tumour cells (with a half-maximal inhibitory concentration of
3.1 κg mL−1)8. A skeletal representation of the cyathins (that is, 2; see Fig. 1) depicts the 20-
carbon tricyclic core bearing two all-carbon quaternary stereocentres at the A–B and B–C ring
junctures. Synthetic control of the relative and absolute stereochemistries of these quaternary
centres along with the construction of the tricyclic framework of the cyathins represent
significant challenges to their laboratory preparation12,13. Despite their structural and
biological significance, only two of the 30 cyanthiwigin molecules isolated so far have been
accessed by total synthesis14,15. Owing to the promising activity and low natural abundance
of these molecules, total synthesis remains an important technique in the production of these
compounds in quantities sufficient for further study. Moreover, a succinct and general approach
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to such a synthetic effort may provide a strategic opportunity for the preparation of many other
members of the cyanthiwigin family.
Our retrosynthetic approach to cyanthiwigin F focused on initial construction of the central B
ring, with the intention of rapidly establishing both of the all-carbon quaternary stereocentres
present at the ring junctures of the natural product (Fig. 1). To this end, we envisioned late-
stage construction of the five-member A ring, leading back to bicyclic ketone 3. We anticipated
that this bicyclic structure would be accessible by means of ring-closing metathesis of
cyclohex-anone 4, which itself could be prepared via Negishi cross-coupling of vinyl triflate
5. Critically, we envisioned that triflate 5 could be obtained from monoanionic
desymmetrization of cyclohexanedione 6 (ref. 16). We recently developed a powerful
methodology for the construction of all-carbon quaternary stereocentres using a chiral
palladium catalyst to mediate the asymmetric alkylation of in situ-generated cyclic ketone
enolates17,18. Using this technology, we anticipated that cyclohexanedione 6 could be
accessed through enantioselective allylation of bis(β-ketoester) 7, which could be generated
from diallyl succinate (8; see Fig. 2a). Indeed, in a model substrate, a double asymmetric
alkylation using our protocol proved successful18.
A key challenge presented by the current system is that it represents the first Pd-catalysed
double stereoablative alkylation event involving two different ketones contained within a single
ring to generate two all-carbon quaternary stereocentres. Additionally, the current substrate is
unique in that a mixture of diastereomers and enantiomers would be converted to a single
stereoisomer of product. This transformation would be particularly noteworthy because non-
selective catalytic ablation of two quaternary centres in the substrate would precede highly
enantio- and diastereoselective construction of two central quaternary centres. Vital to our
overall synthetic plan was that it required no functionality-masking by means of protecting or
caging groups19. Such syntheses are strategically streamlined owing to the lack of protection
and deprotection steps, operations that inherently add two chemical manipulations per
protecting group to any synthetic plan. Although notable examples of protecting group-free
total syntheses exist20-23, they are difficult to accomplish and remain relatively uncommon,
particularly in the catalytic enantioselective total synthesis of complex molecules.
The preparation of the key diketone was initiated by the self-condensation of diallyl succinate
8 using a Claisen–Dieckmann process, which was followed by methylation using potassium
carbonate and methyl iodide to form bis(β-ketoester) 7 in 51% yield over two steps (Fig. 2a)
24. This reaction affords 7 as a 1:1 mixture of racemic ((S, S)-7 plus (R, R)-7) and meso
diastereomers, and can be performed conveniently in 60-g batches of 8. (Routine synthetic
experimental techniques were used for the preparation, isolation, and analysis of all new
compounds and are described in the Supplementary Information.) Having obtained bis(β-
ketoester) 7, we were prepared to expose it to the conditions of our Pd-catalysed
enantioselective allylation. Typically, use of such a stereoisomeric mixture in an asymmetric
transformation would be deleterious to a total synthesis, because the presence of two pre-
existing stereocentres in the substrate could interfere with inherent catalyst selectivity and
afford reduced quantities of the desired product25. The potential for developing mismatched
catalyst–substrate interactions that negatively impact yield and selectivity was a major concern,
as was the possibility of a kinetic resolution26.
The number of possible stereochemical outcomes and the number of pathways leading to each
potential product renders the situation quite complex (Fig. 2b). Beginning from the
diastereomeric mixture of 7, the substrate must initially undergo decarboxylative deallylation
to produce racemic enolate 9, which is subsequently monoalkylated to form ester 10. If the
enantiopure catalyst controls formation of the new stereocentre17,18, a mixture of ester
diastereomers 10 will arise, with (R, R)-10 and (R, S)-10 each predominating over both (S,
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R)-10 and (S, S)-10. Influence of the remaining substrate stereocentre may either reinforce or
conflict with catalyst control during this process. From these intermediate monoesters, a second
stereoablative process would then generate a non-racemic mixture of enolates (R)-11 and
(S)-11. Last, a second facially selective alkylation affords the double alkylation products as a
diastereomeric mixture of enantioenriched (R, R)-6 and meso-6. For the reaction to proceed
favourably a number of criteria must be met: the catalyst must not stereoselectively influence
the stereoablative steps appreciably; the catalyst must impose a high degree of facial selectivity
at all stages of bond construction; and the diastereoselective bias for alkylation inherent in the
substrate must not override the influence of the catalyst. If these requirements are met, it is
expected that the major product of the reaction will benefit from a statistical amplification of
its enantiomeric excess, in line with theories first described in ref. 3 and later detailed both
experimentally and computationally in refs 4–6.
In practice, treatment of a 1:1 mixture of diastereomers (or either pure diastereomer) of bis(β-
ketoester) 7 with Pd(dmdba)2 (5 mol per cent) and enantiopure tert-butyl phosphinooxazoline
(PHOX) ligand27 12 (5.5 mol per cent) in Et2O at 25 °C affords the bisalkylated products
enantioenriched 6 and meso-6 as a 4.4:1 mixture in 78% yield. Moreover, we found that the
major diastereomer of 6 is formed in 99% enantiomeric excess. In this single-step procedure,
two all-carbon quaternary stereocentres were simultaneously constructed with excellent
enantioselectivity, thus addressing what is arguably the greatest synthetic challenge to the
preparation of cyanthiwigin F. It is important to note that although this reaction may progress
through any of sixteen different pathways to afford any of three different stereoisomers, the
high degree of stereoconvergence and stereochemical control imparted by the catalyst system
predominantly favours formation of the desired diketone (R, R)-6.
The completion of the synthesis of cyanthiwigin F (1) proceeds rapidly owing to the high level
of stereochemical value and functionality present in cyclohexanedione 6. Selective
monoenolization of diketone 6 with potassium bis(trimethylsilyl)amide (KHMDS) and
trapping of the resulting potassium enolate as a trifluoromethane-sulfonate is followed by a
Pd-catalysed Negishi cross-coupling to introduce an olefinic side chain and generate tetraene
4 (Fig. 3a)28. To advance this material, we required closure of the seven-member ring, as well
as elaboration of the terminal allyl group to a functional moiety appropriate for completion of
the tricyclic cyathin core. We found that both transformations could be effected with a single
catalytic operation by treating 4 with Grubbs’ ruthenium catalyst 13 (ref. 29) and a vinyl
boronate species (14). This provided an efficient and mild method to simultaneously execute
both ring-closing metathesis to form the C ring and cross-metathesis with vinyl boronate 14
to elaborate the terminal olefin. Upon oxidative work-up, bicyclic aldehyde 15 was isolated in
a single step.
Completion of the carbocyclic core of cyanthiwigin F was then achieved through radical-
induced intramolecular cyclization of the aldehyde moiety in bicyclic compound 15 onto the
trisubstituted olefin of the central B ring. This was accomplished by treatment of 15 with t-
BuSH and azobis(isobutylnitrile) (AIBN) at 80 °C to produce tricyclic diketone 16 as a single
diastereomer30. We found that this reaction afforded only the desired cis-fused A–B ring
juncture with an accompanying trans relationship across the B–C ring fusion. We postulate
that these configurations result from the kinetic formation of the C3–C4 bond, followed by
subsequent kinetic hydrogen atom abstraction at C5 to establish the more thermodynamically
stable ring fusion. Recrystallization of this material from acetonitrile and water allowed for
unambiguous assignment of the relative stereochemistry by X-ray crystallography (Fig. 3b).
Once we had tricyclic compound 16, selective enol triflate formation was followed by a difficult
Pd-catalysed coupling reaction with an i-Pr-organocuprate reagent to afford cyanthiwigin F
(1) and a reduction product (that is, 17) as a 1.8:1 mixture in 63% combined yield. Isolation
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of the major component of this mixture affords cyanthiwigin F in only nine steps from diallyl
succinate.
In conclusion, we have achieved the catalytic enantioselective synthesis of the cyathin
diterpenoid (–)-cyanthiwigin F. Our synthetic route features an enantioselective Pd-catalysed
double alkylation reaction as the pivotal step by which stereochemistry is established about
the central B ring of the molecule. Use of this stereoconvergent approach allowed us to employ
classic scaleable condensation chemistry in the early stages of our route (that is, Claisen–
Dieckmann cyclization), and provided the critical stereochemical information necessary to
guide the final steps of our synthesis. From this point, an efficient tandem ring-closing
metathesis/cross-metathesis reaction followed by a thiol-mediated radical cyclization allowed
for rapid elaboration to the natural product, without the use of protecting groups. This short
synthetic route highlights the utility of double enantioselective transformations in the
construction of molecules with high levels of stereochemical complexity, and uses low catalyst
loading, is not very difficult operationally, and results in exceptional enantioselectivity. We
hope that the results reported here will encourage greater investigation into multiple catalytic
enantioselective processes. Implementation of this strategy for the synthesis of other
cyanthiwigin natural products and studies towards the use of double enantioselective reactions
in the easy preparation of various complex molecules are ongoing.
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Figure 1.
Structure and retrosynthesis of cyanthiwigin F.
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Figure 2. Synthesis of diketone 6
a, Implementation of the double asymmetric alkylation. 8→7: (1) NaH (2.5 equiv.), allyl
alcohol (0.28 equiv.), diallyl succinate (8, 1.0 equiv.), PhMe (toluene), 95 °C, 2 h; (2)
K2CO3 (4.1 equiv.), diallyl succinylsuccinate (1.0 equiv.), MeI (5.1 equiv.), acetone, 50 °C, 6
h, 51% yield over two steps. 7→6: Pd(dmdba)2 (0.05 equiv.), S-t-BuPHOX (12, 0.055 equiv.),
Et2O, 25 °C, precomplexation for 30 min, then bis(β-ketoester) 7 (1.0 equiv.), 25 °C for an
additional 10 h, 78% yield, 4.4:1 diastereomeric ratio (d.r.), 99% enantiomeric excess. b,
Stereochemical analysis for the stereoconvergent double decarboxylative alkylation of 7.
dmdba, bis(3,5-dimethoxybenzylidene)acetone; t-BuPHOX, t-butyl phosphinooxazoline. For
tabulated spectral data of all depicted compounds, please see the Supplementary Information.
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Figure 3. Synthesis of cyanthiwigin F
a, Completion of the cyanthiwigin F (1) synthesis. 6→4: (1) KHMDS (1.1 equiv.), diketone
6 (1.0 equiv.), THF, −78 °C, 30 min, then PhN(Tf)2 (1.2 equiv.), THF, −78 °C, 6 h, 84% yield;
(2) Zn powder (7.5 equiv.), 1,2-dibromoethane (1.2 equiv.), TMSCl (0.33 equiv.), THF, 65 °
C for 15 min, then 4-iodo-2-methyl-1-butene (1.5 equiv.), 65 °C, 2 h, then enol triflate (1.0
equiv.), Pd(PPh3)4 (0.05 equiv.), 65 °C, 3 h, 78% yield. 4→15: Tetraene 4 (1.0 equiv.),
ruthenium catalyst 13 (0.1 equiv.), benzene, 40 °C, 30 min, then vinyl boronate 14 (5.0 equiv.),
40 °C, 20 h, then NaBO3·H2O (6.0 equiv.), THF/H2O, 23 °C, 1 h, 51% yield. 15→16: Bicyclic
aldehyde 15 (1 equiv.), t-butyl thiol (t-BuSH, 3.0 equiv.), AIBN (1.5 equiv.), benzene, 80 °C,
22 h, 57% yield. 16→1: (1) KHMDS (1.1 equiv.), diketone 16 (1 equiv.), THF, −78 °C, 30
min, then PhN(Tf)2 (1.15 equiv.), THF, −78 °C, 3 h, 60% yield; (2) CuCN (1.5 equiv.), i-
PrMgCl (3.0 equiv.), THF, −78 °C to 0 °C, then 0 °C for 10 min, Pd(dppf)Cl2 (0.15 equiv.),
enol triflate (1.0 equiv.), THF, 0 °C, 3 h, 63% yield of a 1.8:1 mixture of 1:17. b, Oak Ridge
Thermal Ellipsoid Plot drawing of 16 (shown with 50% probability ellipsoids). KHMDS,
potassium bis(trimethylsilyl)amide; THF, tetrahydrofuran; PhN(Tf)2, phenyl bis
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(trifluoromethane)sulfonimide; TMSCl, trimethylsilyl chloride; AIBN, 2,2’-azobis
(isobutyronitrile); dppf, 1,1’-bis(diphenylphosphino)ferrocene. For tabulated spectral data of
all depicted compounds, and crystallographic data of tricyclic diketone 16, please see the
Supplementary Information.
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